drugset / Trial / NCT03677297
"Efficacy Of 1.2% Rosuvastatin Gel In The Management Of Infrabony Defects"
RandomizedCrossoverDouble-blindTreatment
Summary
Study aims to evaluate clinical and radiographic effectiveness of 1.2% Rosuvastatin gel in the treatment of Infrabony defects in chronic periodontitis patients.
Timeline
- Start
- 2016-01-28
- Primary completion
- 2017-08-01
- Completion
- 2017-11-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosuvastatin | Small molecule | 1.2 % | Other |